https://webnewsinsider.com/navigating-7-mortgage-rates-strategies-for-buying-a-home-now/ WebNewsInsider en 2026-11-15T19:11:23+08:00 Navigating 7% Mortgage Rates: Strategies for Buying a Home Now https://webnewsinsider.com/how-major-medical-centers-partner-with-tech-firms-for-next-gen-proton-therapy/ WebNewsInsider en 2026-11-15T17:12:33+08:00 How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy https://webnewsinsider.com/fda-denies-approval-for-summit-therapeutics-ivonescimab-in-lung-cancer/ WebNewsInsider en 2026-11-15T16:15:32+08:00 FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer https://webnewsinsider.com/how-will-the-next-era-of-precision-thoracic-oncology-change-treatment-choices-for-lung-cancer-patients/ WebNewsInsider en 2026-11-15T14:11:05+08:00 How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients? https://webnewsinsider.com/fda-approval-moves-astellas-padcev-into-curative-bladder-cancer-setting/ WebNewsInsider en 2026-11-15T09:21:44+08:00 FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting https://webnewsinsider.com/missed-nhs-england-cancer-treatment-target-threatens-bladder-cancer-surgery-waiting-times/ WebNewsInsider en 2026-11-14T19:12:08+08:00 Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times https://webnewsinsider.com/astrazenecas-imfinzi-wins-fda-approval-for-bladder-cancer-patients/ WebNewsInsider en 2026-11-14T03:14:24+08:00 AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients https://webnewsinsider.com/workers-can-boost-tax-savings-by-maximizing-new-3500-health-fsa-limit-for-2027/ WebNewsInsider en 2026-11-14T03:10:55+08:00 Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027